Assay News and Research

RSS
The identification and characterization of an anti-SARS-CoV-2 monoclonal antibody with superior breadth and potency

The identification and characterization of an anti-SARS-CoV-2 monoclonal antibody with superior breadth and potency

28 Jul 2022
Researchers find adeno-associated virus 2 infection in children with hepatitis of unknown etiology

Researchers find adeno-associated virus 2 infection in children with hepatitis of unknown etiology

28 Jul 2022
Icelandic study reveals how many children experience severe COVID symptoms

Icelandic study reveals how many children experience severe COVID symptoms

27 Jul 2022
Efficacy of monoclonal antibodies against Omicron BA.1, BA.2, and BA.5

Efficacy of monoclonal antibodies against Omicron BA.1, BA.2, and BA.5

27 Jul 2022
A comparison of SARS-CoV-2 antibody profiles in elderly and younger individuals

A comparison of SARS-CoV-2 antibody profiles in elderly and younger individuals

27 Jul 2022
The nose key to winning the war against COVID-19

The nose key to winning the war against COVID-19

27 Jul 2022
Investigating an effective linear deoxyribonucleic acid COVID-19 vaccine option for domestic cats

Investigating an effective linear deoxyribonucleic acid COVID-19 vaccine option for domestic cats

27 Jul 2022
Increased resistance to human interferons could be a potential driver of SARS-CoV-2 evolution

Increased resistance to human interferons could be a potential driver of SARS-CoV-2 evolution

27 Jul 2022
Study shows SARS-CoV-2 impairs interferon production through NSP2-induced repression of mRNA translation

Study shows SARS-CoV-2 impairs interferon production through NSP2-induced repression of mRNA translation

27 Jul 2022
Study shows the emerging Omicron sublineage BA.2.75 does not show greater immune evasion than BA.5

Study shows the emerging Omicron sublineage BA.2.75 does not show greater immune evasion than BA.5

27 Jul 2022
The neutralizing antibody response in mRNA vaccinated and boosted healthcare workers against major circulating SARS-CoV-2 Omicron subvariants

The neutralizing antibody response in mRNA vaccinated and boosted healthcare workers against major circulating SARS-CoV-2 Omicron subvariants

27 Jul 2022
FUJIFILM Irvine Scientific Launches Heavy Oil for Embryo Culture: Optimized Protection for the IVF Laboratory

FUJIFILM Irvine Scientific Launches Heavy Oil for Embryo Culture: Optimized Protection for the IVF Laboratory

From FUJIFILM Irvine Scientific 27 Jul 2022
Sixteen countries reported monkeypox virus infection in humans between April and June 2022

Sixteen countries reported monkeypox virus infection in humans between April and June 2022

27 Jul 2022
Study confirms efficacy of molnupiravir against COVID in a real-life cohort

Study confirms efficacy of molnupiravir against COVID in a real-life cohort

26 Jul 2022
Study confirms link between Epstein-Barr virus and multiple sclerosis

Study confirms link between Epstein-Barr virus and multiple sclerosis

26 Jul 2022
Three doses of Novavax vaccine effective against Omicron subvariants

Three doses of Novavax vaccine effective against Omicron subvariants

26 Jul 2022
Bivalent mRNA vaccine induces powerful antibody response to SARS-CoV-2 Omicron subvariants

Bivalent mRNA vaccine induces powerful antibody response to SARS-CoV-2 Omicron subvariants

25 Jul 2022
Scientists identify papain-like protease inhibitor against COVID-19

Scientists identify papain-like protease inhibitor against COVID-19

25 Jul 2022
Study may help overcome some obstacles to the development of nanoparticle-based drugs

Study may help overcome some obstacles to the development of nanoparticle-based drugs

21 Jul 2022
Are Mexican free-tailed bats a SARS-CoV-2 reservoir?

Are Mexican free-tailed bats a SARS-CoV-2 reservoir?

21 Jul 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback